Medtronic Nabs Clearance for OsteoCool
The FDA has blessed Irish devicemaker Medtronic with 510(k) clearance for its OsteoCool RF ablation system.
Featuring cooled radiofrequency ablation technology, the system uses targeted high-frequency energy to destroy cancer cells.
According to Medtronic, the device offers simultaneous, dual-probe capabilities, providing procedural flexibility, as well as predictable, customized treatment.
The devicemaker also announced the U.S. launch of the system. — Michael Cipriano